Dr. Madhav V. Dhodapkar, M.D.
Claim this profileEmory University
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
3 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Madhav V. Dhodapkar, M.D. is currently running
REGN5458
for Multiple Myeloma
The main purpose of this study is to learn about the safety of REGN5458 and to find out what is the best dose of REGN5458 to give to patients with multiple myeloma. An additional purpose is to look for any signs that REGN5458 can treat cancer. The study is looking at several other research questions, including: * Side effects that may be experienced by people receiving REGN5458 * How REGN5458 works in the body * How much REGN5458 is present in the blood * How REGN5458 may work to treat cancer
Recruiting1 award Phase 1 & 2
Rifaximin
for Monoclonal Gammopathy
This trial studies how well rifaximin, an oral antibiotic, works in treating patients with monoclonal gammopathy. It aims to reduce abnormal blood proteins or cells by killing intestinal bacteria. Rifaximin has been used successfully for CDI treatment but lacks United States Food and Drug Administration approval for this indication.
Recruiting3 awards Phase 13 criteria
More about Madhav V. Dhodapkar, M.D.
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Madhav V. Dhodapkar, M.D. has experience with
- Rifaximin
- Anti-LAG-3
- Anti-TIGIT
- Dexamethasone
- Elotuzumab
- Pomalidomide
Breakdown of trials Madhav V. Dhodapkar, M.D. has run
Multiple Myeloma
Plasma Cell Neoplasm
Waldenstrom's Macroglobulinemia
Monoclonal Gammopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Madhav V. Dhodapkar, M.D. specialize in?
Madhav V. Dhodapkar, M.D. focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Madhav V. Dhodapkar, M.D. currently recruiting for clinical trials?
Yes, Madhav V. Dhodapkar, M.D. is currently recruiting for 2 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Madhav V. Dhodapkar, M.D. has studied deeply?
Yes, Madhav V. Dhodapkar, M.D. has studied treatments such as Rifaximin, Anti-LAG-3, Anti-TIGIT.
What is the best way to schedule an appointment with Madhav V. Dhodapkar, M.D.?
Apply for one of the trials that Madhav V. Dhodapkar, M.D. is conducting.
What is the office address of Madhav V. Dhodapkar, M.D.?
The office of Madhav V. Dhodapkar, M.D. is located at: Emory University, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.